Goodman KE - Search Results

1

Considerations for the Use of Phage Therapy in Clinical Practice.

Suh GA, Lodise TP, Tamma PD, Knisely JM, Alexander J, Aslam S, Barton KD, Bizzell E, Totten KMC, Campbell JL, Chan BK, Cunningham SA, Goodman KE, Greenwood-Quaintance KE, Harris AD, Hesse S, Maresso A, Nussenblatt V, Pride D, Rybak MJ, Sund Z, van Duin D, Van Tyne D, Patel R; Antibacterial Resistance Leadership Group. Suh GA, et al. Among authors: goodman ke. Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0207121. doi: 10.1128/AAC.02071-21. Epub 2022 Jan 18. Antimicrob Agents Chemother. 2022. PMID: 35041506 Free PMC article. Review.

2

Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).

Goodman KE, Simner PJ, Tamma PD, Milstone AM. Goodman KE, et al. Expert Rev Anti Infect Ther. 2016;14(1):95-108. doi: 10.1586/14787210.2016.1106940. Epub 2015 Nov 4. Expert Rev Anti Infect Ther. 2016. PMID: 26535959 Review.

3

A Clinical Decision Tree to Predict Whether a Bacteremic Patient Is Infected With an Extended-Spectrum β-Lactamase-Producing Organism.

Goodman KE, Lessler J, Cosgrove SE, Harris AD, Lautenbach E, Han JH, Milstone AM, Massey CJ, Tamma PD; Antibacterial Resistance Leadership Group. Goodman KE, et al. Clin Infect Dis. 2016 Oct 1;63(7):896-903. doi: 10.1093/cid/ciw425. Epub 2016 Jun 28. Clin Infect Dis. 2016. PMID: 27358356 Free PMC article.

4

Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.

Tamma PD, Goodman KE, Harris AD, Tekle T, Roberts A, Taiwo A, Simner PJ. Tamma PD, et al. Among authors: goodman ke. Clin Infect Dis. 2017 Feb 1;64(3):257-264. doi: 10.1093/cid/ciw741. Epub 2016 Nov 9. Clin Infect Dis. 2017. PMID: 28013264 Free PMC article.

5

Using Patient Risk Factors to Identify Whether Carbapenem-Resistant Enterobacteriaceae Infections Are Caused by Carbapenemase-Producing Organisms.

Simner PJ, Goodman KE, Carroll KC, Harris AD, Han JH, Tamma PD. Simner PJ, et al. Among authors: goodman ke. Open Forum Infect Dis. 2018 May 17;5(5):ofy094. doi: 10.1093/ofid/ofy094. eCollection 2018 May. Open Forum Infect Dis. 2018. PMID: 29876368 Free PMC article.

6

A Decision Tree Using Patient Characteristics to Predict Resistance to Commonly Used Broad-Spectrum Antibiotics in Children With Gram-Negative Bloodstream Infections.

Sick-Samuels AC, Goodman KE, Rapsinski G, Colantouni E, Milstone AM, Nowalk AJ, Tamma PD. Sick-Samuels AC, et al. Among authors: goodman ke. J Pediatric Infect Dis Soc. 2020 Apr 30;9(2):142-149. doi: 10.1093/jpids/piy137. J Pediatric Infect Dis Soc. 2020. PMID: 30690525 Free PMC article.

7

A methodological comparison of risk scores versus decision trees for predicting drug-resistant infections: A case study using extended-spectrum beta-lactamase (ESBL) bacteremia.

Goodman KE, Lessler J, Harris AD, Milstone AM, Tamma PD. Goodman KE, et al. Infect Control Hosp Epidemiol. 2019 Apr;40(4):400-407. doi: 10.1017/ice.2019.17. Epub 2019 Mar 4. Infect Control Hosp Epidemiol. 2019. PMID: 30827286

8

Predicting probability of perirectal colonization with carbapenem-resistant Enterobacteriaceae (CRE) and other carbapenem-resistant organisms (CROs) at hospital unit admission.

Goodman KE, Simner PJ, Klein EY, Kazmi AQ, Gadala A, Toerper MF, Levin S, Tamma PD, Rock C, Cosgrove SE, Maragakis LL, Milstone AM; CDC Prevention Epicenters Program. Goodman KE, et al. Infect Control Hosp Epidemiol. 2019 May;40(5):541-550. doi: 10.1017/ice.2019.42. Epub 2019 Mar 27. Infect Control Hosp Epidemiol. 2019. PMID: 30915928 Free PMC article.

9

The Likelihood of Developing a Carbapenem-Resistant Enterobacteriaceae Infection during a Hospital Stay.

Tamma PD, Kazmi A, Bergman Y, Goodman KE, Ekunseitan E, Amoah J, Simner PJ. Tamma PD, et al. Among authors: goodman ke. Antimicrob Agents Chemother. 2019 Jul 25;63(8):e00757-19. doi: 10.1128/AAC.00757-19. Print 2019 Aug. Antimicrob Agents Chemother. 2019. PMID: 31138574 Free PMC article.

10

Evaluation of the Direct MacConkey Method for Identification of Carbapenem-Resistant Gram-Negative Organisms from Rectal Swabs: Reevaluating Zone Diameter Cutoffs.

Workneh M, Wang R, Kazmi AQ, Chambers KK, Opene BNA, Lewis S, Goodman K, Tamma PD, Carroll KC, Milstone AM, Simner PJ. Workneh M, et al. J Clin Microbiol. 2019 Nov 22;57(12):e01127-19. doi: 10.1128/JCM.01127-19. Print 2019 Dec. J Clin Microbiol. 2019. PMID: 31597748 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page